0000874015-13-000100.txt : 20130911 0000874015-13-000100.hdr.sgml : 20130911 20130911192616 ACCESSION NUMBER: 0000874015-13-000100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130909 FILED AS OF DATE: 20130911 DATE AS OF CHANGE: 20130911 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PARSHALL B LYNNE CENTRAL INDEX KEY: 0001073385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 131091935 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2013-09-09 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001073385 PARSHALL B LYNNE C/O ISIS PHARMACEUTICALS, INC. 2855 GAZELLE COURT CARLSBAD CA 92010 1 1 0 0 COO Common Stock 2013-09-09 2013-09-09 4 M 0 30000 15.38 A 32941 D Common Stock 2013-09-09 2013-09-09 4 S 0 30000 30.415 D 2941 D Common Stock 2013-09-10 2013-09-10 4 M 0 30000 15.38 A 32941 D Common Stock 2013-09-10 2013-09-10 4 S 0 30000 31.648 D 2941 D Common Stock 2013-09-11 2013-09-11 4 M 0 1520 15.38 A 4461 D Common Stock 2013-09-11 2013-09-11 4 S 0 1520 31.181 D 2941 D Common Stock 2013-09-11 2013-09-11 4 S 0 1985 31.181 D 956 D Employee Stock Option (right to buy) 15.38 2013-09-09 2013-09-09 4 M 0 30000 0 D 2012-01-02 2015-01-01 Common Stock 30000 61520 D Employee Stock Option (right to buy) 15.38 2013-09-10 2013-09-10 4 M 0 30000 0 D 2012-01-02 2015-01-01 Common Stock 30000 31520 D Employee Stock Option (right to buy) 15.38 2013-09-11 2013-09-11 4 M 0 1520 0 D 2012-01-02 2015-01-01 Common Stock 1520 30000 D Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 8/6/2013. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/6/2013. /s/B. Lynne Parshall 2013-09-11